FDA advisers recommend approval of Pfizer’s Covid vaccine for kids aged 5-11

Nearly unanimous vote clears the way for possible approval for emergency use next month, making nearly 30m children eligible

Independent advisers for the US Food and Drug Administration (FDA) on Tuesday recommended the Pfizer-BioNTech Covid vaccine for children aged five to 11 - the first vaccine available for younger children in the US.

Of 18 members, 17 voted yes and one abstained.